About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
ResponsibilityBeing the largest Polish pharmaceutical company we want to help people to live a healthy life in a healthy world. Social responsibility is an integral part of the management strategy in our company.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
PRICE INQUIRY No. SEMA/62/PR108349/2025 – being conducted as a market assessment study27 May 2025In connection with the implementation of the project titled “Design and development of an innovative solution – a drug from the group of GLP-1 receptor… read more
Other PRICE INQUIRY No. NUSI/122/PR98053/2025- being conducted as a market assessment study15 May 2025In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
Company News Polpharma Group Joins the Call to Action to Finalize Pharmaceutical Reform and Secure Early and Sustainable Healthcare for European Patients13 May 2025Commitment to Health Security Public health is a fundamental right. As EU Health Ministries approach the final stages of negotiations on the future of Europe’s… read more
PRICE INQUIRY No. NUSI/121/487645/2025- being conducted as a market assessment study28 April 2025In connection with the implementation of the project titled “ Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and… read more
PRICE INQUIRY No. NUSI 112/PR92515/2025 conducted in the mode of market research25 April 2025In connection with the implementation of the project entitled. „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological… read more
